MarketLens
Sign Up
Stock Analysis

Did Moderna's Q4 Earnings Beat Outweigh the Flu Vaccine Setback

8 months ago
SHARE THIS ON:

Did Moderna's Q4 Earnings Beat Outweigh the Flu Vaccine Setback

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

Already a Pro member? Log in
SHARE THIS ON:

Related Articles

Moderna's Flu Vaccine Surge: A Chasm Between Market Hype and Wall Street's Skepticism

Moderna's Flu Vaccine Surge: A Chasm Between Market Hype and Wall Street's Skepticism

3 months ago
Did CF Industries' Q4 2025 Earnings Beat Signal a Turning Point

Did CF Industries' Q4 2025 Earnings Beat Signal a Turning Point

8 months ago
Has Target Finally Turned the Corner After Its Q4 Earnings Beat

Has Target Finally Turned the Corner After Its Q4 Earnings Beat

8 months ago
Is New Gold (NGD) Poised for a Q4 Earnings Beat

Is New Gold (NGD) Poised for a Q4 Earnings Beat

8 months ago

Category

TopFeaturedPro OnlyStock AnalysisInvestment IdeasETFsCrypto

You may also like

Stock News•1 months ago

Does Moderna's mRNA Flu Shot Face a New Challenge From GSK?

Moderna's newly approved mFlusiva faces a potential challenge as GSK advances an mRNA flu vaccine targeting two viral proteins, which could intensify competition in the flu vaccine market.
MRNA
Stock News•3 months ago

MRNA Q2 Earnings Meet, Stock Down on Norovirus Vaccine Setback

Moderna shares fell after Q2 revenue topped estimates, because its phase III norovirus vaccine study missed early success criteria. The setback clouds the company's pipeline outlook despite the earnin...
MRNA
Stock News•3 months ago

Moderna Is Up More Than 70% in a Month After a 9-0 FDA Vote. Wall Street's Average Price Target Says It Should Fall 44%.

Moderna rose over 70% in a month after an FDA panel voted 9-0 that its mRNA flu vaccine's benefits outweigh risks. A final approval decision is expected by Aug. 5.
MRNA

Breaking News

View All →
Earnings
Earnings Surprise
AI Hype
Analyst Consensus
EPS Beat/Miss
Litigation Finance

Featured Articles

DoorDash (DASH): Founder Selling Signals Liquidity, Not Lack of Confidence Amid Robust Growth

DoorDash (DASH): Founder Selling Signals Liquidity, Not Lack of Confidence Amid Robust Growth

2 months ago
Sea Limited's Growth Momentum Outweighs COO's Programmed De-risking

Sea Limited's Growth Momentum Outweighs COO's Programmed De-risking

2 months ago
Arista Networks' AI Momentum Encounters Founder's Planned Profit-Taking

Arista Networks' AI Momentum Encounters Founder's Planned Profit-Taking

2 months ago

Top Headlines

View More →
Stock News•26 minutes ago

Google parent Alphabet suffers nearly $500B Wall Street wipeout amid AI spending fears

Stock News•53 minutes ago

Amazon the Latest Mag 7 to Miss Q3 Estimates

Stock News•1 hour ago

20 Years of S&P 500 History Show: This Simple Strategy Is Only 8.3% Less Than "Perfect"

Stock News•1 hour ago

Microsoft Q1: Capex Shouldn't Scare You Due To Free Cash Flow

Stock News•1 hour ago

Microsoft Took The Balanced Approach To AI - Now It's The King